Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for negative symptoms in inpatients with schizophrenia
IRCT2014031211071N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in schizophrenia, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in negative symptoms of schizophrenia. Started Aug 2012; status: completed.
02
Drugs
ondansetron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT2014031211071N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014031211071N2.